Information updates

ASCIA Generic Action and First Aid Plans for Anaphylaxis now include QR codes

With the widespread use of QR codes, and two brands of adrenaline (epinephrine) injector devices now available, a QR code has been added to the generic version of the red ASCIA Action Plan for Anaphylaxis and the generic version of the orange ASCIA First Aid Plan for Anaphylaxis. 

The QR code links to a new ASCIA webpage www.allergy.org.au/hp/anaphylaxis/how-to-give-injector which includes instructions for both EpiPen® and Anapen® . Please note that the generic versions with QR codes are not intended to replace the device specific plans for EpiPen® and Anapen®

The generic ASCIA plans with QR codes are now available on the ASCIA website in several locations and have been updated in ASCIA anaphylaxis e-training courses:

www.allergy.org.au/hp/anaphylaxis/ascia-action-plan-for-anaphylaxis

www.allergy.org.au/hp/ascia-plans-action-and-treatment

www.allergy.org.au/hp/anaphylaxis/first-aid-for-anaphylaxis

The generic versions of ASCIA plans have been available for several years, for the following reasons:

  • To enable translations, generic orange ASCIA First Aid Plan for Anaphylaxis were introduced in 2012.
  • To prepare for the situation where other brands of adrenaline injector devices may have been introduced at short notice, due to supply issues, generic red ASCIA Action Plans for Anaphylaxis were introduced in 2018.
  • To provide a illustrative training tool, without being brand specific, generic red ASCIA Action Plans for Anaphylaxis and orange ASCIA First Aid Plan for Anaphylaxis have been used in ASCIA anaphylaxis e-training courses since 2018.

Adding the QR code to the generic ASCIA plans provides additional information to ‘refer to device label’ for instructions. Even if people don’t use the QR code, having the code in a prominent location may highlight the fact that people can ‘refer to device label’ for instructions.

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.